Biological Skincare: From Anti-Aging Claims to Age-Empowered Beauty

Introduction

Over the past decade, the skincare industry has undergone a profound transformation. Traditional anti-aging claims are evolving toward a broader and more meaningful concept: healthy skin ageing. This shift reflects advances in biotech ingredients, cellular biology, and clinical research, as well as a fundamental change in consumer expectations.

Today’s consumers are increasingly science-literate, ingredient-conscious, and health-oriented. As a result, brands are now discussing beauty at the cellular and molecular level, positioning skincare as an active contributor to skin health rather than merely a cosmetic mask for aging.

Consumer influence and the healthy skin ageing movement

Consumer behaviour is a powerful catalyst for this transformation. Instead of opposing chronological age, consumers now demand functional skin health: stronger barrier integrity, long-term hydration, protection from environmental stressors, and preservation of youthful cellular activity.

This shift compels brands to redefine how efficacy is measured. Claims must demonstrate biological relevance, durability of effect, and mechanistic plausibility, moving beyond short-term cosmetic improvements toward outcomes that reflect meaningful support of skin physiology.

Redefining anti-aging claims: from surface signs to biological health

What if anti-aging claims were redefined to target the biological mechanisms that drive aging rather than simply concealing its visible effects? From a biological perspective, skin aging involves several biological mechanisms. Proteins orchestrate nearly all cellular processes, and recent literature emphasizes that oxidative stress and the accumulation of damaged or misfolded proteins are central drivers of skin aging (1). This understanding opens new scientific opportunities to position skincare within the framework of longevity science and to redefine efficacy claims on a biological basis.

Scientific literature increasingly highlights the importance of preserving biological integrity to extend what can be described as skin healthspan: the period during which skin remains functional, resilient, and capable of maintaining homeostasis against intrinsic and environmental stressors. Skin healthspan, or “skinspan,” refers not only to the absence of wrinkles but to the maintenance of healthy, responsive, and biologically competent skin (2). Adapted from systemic longevity research, this concept shifts the focus from correction to targeting the molecular drivers of aging. Core mechanisms such as mitochondrial activity, redox balance, autophagic flux, and senescence regulation are becoming central targets for next-generation cosmetic science (3).

Recent research also emphasizes the close interdependence between proteostasis and autophagy in maintaining youthful skin function, describing how modulation of protein quality-control systems may represent promising strategies to counteract skin aging (4). By supporting ECM integrity and intracellular protein homeostasis, these approaches strengthen the biological foundation of skin resilience.

Cellular senescence has emerged as another fundamental driver of skin aging. Targeting senescent cells through senolytic strategies represents a promising direction for managing both skin aging and senescence-associated skin diseases (5). This opens new perspectives for cosmetic science to act upstream of visible aging signs.

Claim substantiation and scientific credibility in skincare

In this new landscape, claim substantiation is central to scientific credibility, evidence-based, and robust testing methodologies. The historical reliance on before-and-after photographs or subjective questionnaires is no longer sufficient, particularly for products claiming biological activity on aging mechanisms.

A rigorous framework for substantiating longevity-driven cosmetic claims has been proposed (2), based on four pillars:

1. Targeting hallmarks of aging with a strong biological rationale,
2. Demonstrating measurable improvements in skin viability and function,
3. Validation through clinical trials, including molecular biomarkers, and
4. Comprehensive safety evaluation.

This framework marks a transition from cosmetic performance alone to genuine biological relevance, reinforcing consumer trust and strengthening scientific integrity.

Preclinical testing is essential for understanding mechanisms of action. Advanced in vitro models allow evaluation of how ingredients modulate oxidative stress, autophagy, mitochondrial function, and senescence pathways. Ex vivo human skin biopsies further bridge laboratory research with physiological relevance. Clinical trials remain the gold standard; modern protocols combine instrumental measurements of elasticity, hydration, and barrier function with emerging biomarkers of skin aging. HR imaging, confocal microscopy, and AI-based analysis tools allow quantification of biological changes, strengthening the link between claim communication and measurable results, and demonstrating changes in the skin’s biological age, not only cosmetic appearance.

Biological innovation: Biotech-derived peptides and fermented ingredients

In parallel, sustainability and biotech are reshaping ingredient development. Traditional actives such as botanical extracts, antioxidants, and retinoids remain essential, but they are increasingly complemented by biotechnological solutions derived from fermentation, synthetic biology, and precision microbiology.

Fermentation technologies enhance the bioavailability, stability, and reproducibility of active ingredients while reducing environmental impact. These properties make them particularly relevant for supporting mitochondrial function and restoring cellular homeostasis in aging skin. Biotech-derived peptides and precision-fermented polysaccharides, including advanced hyaluronic acid analogues, are also gaining importance. These molecules aim to act on fundamental aging mechanisms by modulating extracellular matrix synthesis, mitochondrial metabolism, and intercellular communication.

Pathways such as senescence modulation, proteostasis restoration, and metabolic optimization are no longer confined to therapeutic research but are becoming relevant for preventive and supportive skincare strategies (6). Nowadays, one of the most important frameworks driving ingredient innovation is the Hallmarks of Aging (7), which outlines the cellular and molecular mechanisms that contribute to aging.

An age-empowered future

The future of skincare lies at the intersection of biology, sustainability, and evidence-based innovation. Anti-aging is no longer about erasing time but about empowering skin to function optimally at every stage of life. Advances in proteostasis science, fermentation biotech, senescence biology, and longevity research are redefining what cosmetic efficacy represents.

As the industry adopts rigorous claim substantiation and embraces biological relevance, skincare is evolving into a genuine partner of healthy aging. This transformation establishes a new beauty paradigm rooted in transparency, empowerment, and trust, where science is not a marketing tool but the foundation of meaningful product innovation.

References and notes

1. Dréno B, Benoit I, Perrier E, Radman M. (2024). Beyond the genome: protecting the proteome may be the key to preventing skin aging. Eur J Dermatol. 2024 Aug 1;34(4):355-360. DOI: https://pubmed.ncbi.nlm.nih.gov/39193671/
2. Kream E, Fabi S, and Boen M. (2025). Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence‐Based Interventions. J Cosmet Dermatol. 2025 Sep 6;24(9): e70432. DOI: NONBREAKING_SPACEhttps://doi.org/10.1111/jocd.70432
3. Klinngam W, et al. (2025). Longevity cosmeceuticals as the next frontier in cosmetic innovation: a scientific framework for substantiating product claims. Front Aging. 2025 May 22;6:1586999. DOI: https://pubmed.ncbi.nlm.nih.gov/40475790/
4. Wang S, et al. (2025). Promoting collagen synthesis: a viable strategy to combat skin ageing. J Enzyme Inhib Med Chem. 40(1). DOI:NONBREAKING_SPACEhttps://pubmed.ncbi.nlm.nih.gov/40213810/
5. Thau H, et al. (2025). Senescence as a molecular target in skin aging and disease, Ageing Research Reviews, Volume 105, 2025, 102686. DOI: https://www.sciencedirect.com/science/article/pii/S1568163725000327?utm_source=chatgpt.com
6. Furman D, et al. (2025). Skin health and biological aging. Nat Aging. 2025 Jul;5(7):1195-1206. DOI: https://pubmed.ncbi.nlm.nih.gov/40527938/
7. López-Otín C, et al. (2023). Hallmarks of aging: An expanding universe. Cell.NONBREAKING_SPACE2023 Jan 19;186(2):243-278.NONBREAKING_SPACEEpub 2023 Jan 3. DOI:NONBREAKING_SPACE10.1016/j.cell.2022.11.001